Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study (Q46689862)

24 December 2017

title

Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study (English)

1 reference

24 December 2017

0 references

Saverio Stranges

1

1 reference

24 December 2017

Lisa B Rafalson

2

1 reference

24 December 2017

Jacek Dmochowski

3

1 reference

24 December 2017

Karol Rejman

4

1 reference

24 December 2017

Russell P Tracy

5

1 reference

24 December 2017

Maurizio Trevisan

6

1 reference

24 December 2017

Richard P Donahue

7

1 reference

24 December 2017

publication date

20 March 2008

1 reference

24 December 2017

published in

Obesity

1 reference

24 December 2017

volume

16

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

1370-1376

1 reference

24 December 2017

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the atherosclerosis risk in communities study: 1987-1998

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Predicting diabetes. Moving beyond impaired glucose tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Use and misuse of the receiver operating characteristic curve in risk prediction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Inflammatory markers and risk of developing type 2 diabetes in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Body mass index, diabetes, and C-reactive protein among U.S. adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Obesity and the role of adipose tissue in inflammation and metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

The leukocyte count: associations with intensity of smoking and persistence of effect after quitting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Adiponectin and development of type 2 diabetes in the Pima Indian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Adiponectin and protection against type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

The performance of a risk score in predicting undiagnosed hyperglycemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

A Danish diabetes risk score for targeted screening: the Inter99 study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Routinely collected general practice data aids identification of people with hyperglycaemia and metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.59

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.59

1 reference

24 December 2017

1 reference

24 December 2017